<p>Ondine Biomedical Inc.（倫敦證券交易所代碼：OBI - 獲取免費報告）的股票在週四創下了 52 周新低。該股最低交易價格為 7.50 加元，最後交易價格為 8.00 加元，成交量為 89210 股。該股此前收盤價為 8.00 加元。</p>
<p>獲取 <strong>Ondine Biomedical</strong> 的提醒：</p>
<h2>Ondine Biomedical 價格表現</h2>
<p>該公司的 50 日移動平均線為 9.79 加元，200 日移動平均線為 12.56 加元。該股市值為 41.5 億加元，市盈率為-1.14，貝塔值為 0.10。公司債務與股本比率為 25.95，速動比率為 8.26，流動比率為 1.36。</p>
<h2>關於 Ondine Biomedical</h2>
<p>（獲取免費報告）</p>
<p>Ondine Biomedical 是一家生命科學公司，致力於開發突破性的光消毒療法，以預防和治療嚴重感染，包括由現有、正在出現和抗微生物耐藥病原體引起的感染。我們的願景是創造一個無感染的世界。我們創造了一種專利的平台技術（光消毒），為醫療和工業領域的複雜感染提供簡單的解決方案。我們專注於滿足重大需求、易於部署、環保、安全並且成本僅為目標感染的一小部分的解決方案。我們的光消毒技術在加拿大的醫院、診所和工業環境中成功應用於超過 100,000 例患者治療。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Ondine Biomedical</li>
<li>華爾街提醒：買入 AES</li>
<li>巴菲特、蓋茨和貝索斯悄然拋售股票——原因在這裏</li>
<li>特朗普的手寫信將震驚他的反對者</li>
<li>比特幣下跌，但你的收入即將暴漲</li>
<li>崩盤前一個月</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 Ondine Biomedical 嗎？</h2>
<p>在你考慮 Ondine Biomedical 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而 Ondine Biomedical 並不在名單上。</p>
<p>雖然 Ondine Biomedical 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>Ondine Biomedical (LON:OBI) 的股票跌至新的 52 周低點 C$7.50，最後交易價格為 C$8.00，成交量為 89,210 股。該股票的 50 日移動平均線為 C$9.79，200 日移動平均線為 C$12.56。公司的市值為 C$41.5 億，市盈率為-1.14。分析師目前對該股票的評級為持有，但它並不是分析師推薦的頂級股票之一</p>

<p>Shares of Ondine Biomedical Inc. (LON:OBI - Get Free Report) hit a new 52-week low on Thursday . The stock traded as low as C$7.50 and last traded at C$8.00, with a volume of 89210 shares traded. The stock had previously closed at C$8.00.</p>
<div class="lb-trans"><p>Ondine Biomedical Inc.（倫敦證券交易所代碼：OBI - 獲取免費報告）的股票在週四創下了 52 周新低。該股最低交易價格為 7.50 加元，最後交易價格為 8.00 加元，成交量為 89210 股。該股此前收盤價為 8.00 加元。</p>
</div><p>Get <strong>Ondine Biomedical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Ondine Biomedical</strong> 的提醒：</p>
</div><h2>Ondine Biomedical Price Performance</h2>
<div class="lb-trans"><h2>Ondine Biomedical 價格表現</h2>
</div><p>The business's 50 day moving average is C$9.79 and its 200-day moving average is C$12.56. The stock has a market cap of C$4.15 billion, a price-to-earnings ratio of -1.14 and a beta of 0.10. The company has a debt-to-equity ratio of 25.95, a quick ratio of 8.26 and a current ratio of 1.36.</p>
<div class="lb-trans"><p>該公司的 50 日移動平均線為 9.79 加元，200 日移動平均線為 12.56 加元。該股市值為 41.5 億加元，市盈率為-1.14，貝塔值為 0.10。公司債務與股本比率為 25.95，速動比率為 8.26，流動比率為 1.36。</p>
</div><h2>About Ondine Biomedical</h2>
<div class="lb-trans"><h2>關於 Ondine Biomedical</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens. Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target. Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.</p>
<div class="lb-trans"><p>Ondine Biomedical 是一家生命科學公司，致力於開發突破性的光消毒療法，以預防和治療嚴重感染，包括由現有、正在出現和抗微生物耐藥病原體引起的感染。我們的願景是創造一個無感染的世界。我們創造了一種專利的平台技術（光消毒），為醫療和工業領域的複雜感染提供簡單的解決方案。我們專注於滿足重大需求、易於部署、環保、安全並且成本僅為目標感染的一小部分的解決方案。我們的光消毒技術在加拿大的醫院、診所和工業環境中成功應用於超過 100,000 例患者治療。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Ondine Biomedical</li>
<li>Wall Street Alert: Buy AES</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
<li>Trump’s Hand-Written Letter Will Shock his Haters</li>
<li>Bitcoin is down but your income is about to explode</li>
<li>A month before the crash</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Ondine Biomedical</li>
<li>華爾街提醒：買入 AES</li>
<li>巴菲特、蓋茨和貝索斯悄然拋售股票——原因在這裏</li>
<li>特朗普的手寫信將震驚他的反對者</li>
<li>比特幣下跌，但你的收入即將暴漲</li>
<li>崩盤前一個月</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Ondine Biomedical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Ondine Biomedical 嗎？</h2>
</div><p>Before you consider Ondine Biomedical, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Ondine Biomedical 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ondine Biomedical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而 Ondine Biomedical 並不在名單上。</p>
</div><p>While Ondine Biomedical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Ondine Biomedical 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Ondine Biomedical (LON:OBI) 創下 12 個月新低 - 以下是發生的情況